Analyst Ratings for Annexon Biosciences (ANNX)
ANNX Rating Summary
ANNX Price Target Summary
- Highest: $27.00 (Wells Fargo)
- Lowest: $3.00 (Citizens)
- Average: $14.88
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$14.88 (+190%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 86%
Avg. $ Target:
$14.88 (+190%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/21/2026 | Citizens | Jonathan Wolleben | New Coverage | Market Underperform (N/A) |
3.00 (N/A) |
5.80 (5.13) |
-11.55% | Details |
| 5/12/2026 | Goldman Sachs | Salveen Richter | New Coverage | Neutral (N/A) |
7.00 (N/A) |
5.68 (5.13) |
-9.68% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
